Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Removing instabilities in the hierarchical equations of motion: Exact and approximate projection approaches.

Dunn IS, Tempelaar R, Reichman DR.

J Chem Phys. 2019 May 14;150(18):184109. doi: 10.1063/1.5092616.

PMID:
31091920
2.

Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells.

Haggerty TJ, Dunn IS, Rose LB, Newton EE, Pandolfi F, Kurnick JT.

PLoS One. 2014 Dec 12;9(12):e114506. doi: 10.1371/journal.pone.0114506. eCollection 2014.

3.

Are molecular alphabets universal enabling factors for the evolution of complex life?

Dunn IS.

Orig Life Evol Biosph. 2013 Dec;43(6):445-64. doi: 10.1007/s11084-014-9354-9. Epub 2014 Feb 9.

PMID:
24510462
4.

A screening assay to identify agents that enhance T-cell recognition of human melanomas.

Haggerty TJ, Dunn IS, Rose LB, Newton EE, Kurnick JT.

Assay Drug Dev Technol. 2012 Apr;10(2):187-201. doi: 10.1089/adt.2011.0379. Epub 2011 Nov 15.

5.

RNA templating of molecular assembly and covalent modification patterning in early molecular evolution and modern biosystems.

Dunn IS.

J Theor Biol. 2011 Sep 7;284(1):32-41. doi: 10.1016/j.jtbi.2011.06.009. Epub 2011 Jun 17.

PMID:
21703277
6.

Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells.

Haggerty TJ, Dunn IS, Rose LB, Newton EE, Martin S, Riley JL, Kurnick JT.

Cancer Immunol Immunother. 2011 Jan;60(1):133-44. doi: 10.1007/s00262-010-0926-x. Epub 2010 Oct 30.

7.

Strategies to overcome obstacles to successful immunotherapy of melanoma.

Pandolfi F, Cianci R, Lolli S, Dunn IS, Newton EE, Haggerty TJ, Boyle LA, Kurnick JT.

Int J Immunopathol Pharmacol. 2008 Jul-Sep;21(3):493-500. Review.

8.

Enhancement of human melanoma antigen expression by IFN-beta.

Dunn IS, Haggerty TJ, Kono M, Durda PJ, Butera D, Macdonald DB, Benson EM, Rose LB, Kurnick JT.

J Immunol. 2007 Aug 15;179(4):2134-42.

9.

Role of the mitogen-activated protein kinase signaling pathway in the regulation of human melanocytic antigen expression.

Kono M, Dunn IS, Durda PJ, Butera D, Rose LB, Haggerty TJ, Benson EM, Kurnick JT.

Mol Cancer Res. 2006 Oct;4(10):779-92.

10.

Translocations into human chromosome 14 JH region: factors influencing downstream abortive immunoglobulin class switching.

Hughes JA, Weckert HA, van Holst Pellekaan C, Benson EM, Dunn IS.

Mol Immunol. 2003 Dec;40(9):573-83.

PMID:
14597160
11.

Induction of "antigen silencing" in melanomas by oncostatin M: down-modulation of melanocyte antigen expression.

Durda PJ, Dunn IS, Rose LB, Butera D, Benson EM, Pandolfi F, Kurnick JT.

Mol Cancer Res. 2003 Apr;1(6):411-9.

13.

A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter.

Kurnick JT, Ramirez-Montagut T, Boyle LA, Andrews DM, Pandolfi F, Durda PJ, Butera D, Dunn IS, Benson EM, Gobin SJ, van den Elsen PJ.

J Immunol. 2001 Aug 1;167(3):1204-11.

14.

Quantifiable analysis of human immunoglobulin heavy chain class-switch recombination to all isotypes.

Weckert HA, Hughes JA, Benson EM, Dunn IS.

J Immunol Methods. 2000 Jan 13;233(1-2):141-58.

PMID:
10648864
15.

Expression and localization of the retinoblastoma gene during radiation-induced apoptosis in neonatal rat kidney.

Gobé GC, Halliday J, Dunn IS, Harmon BV, Schoch E, Khan SM, Allan DJ.

Exp Cell Res. 1997 Sep 15;235(2):354-61.

PMID:
9299159
16.

Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells.

Parsons PG, Hansen C, Fairlie DP, West ML, Danoy PA, Sturm RA, Dunn IS, Pedley J, Ablett EM.

Biochem Pharmacol. 1997 Jun 1;53(11):1719-24.

PMID:
9264325
17.

Biphasic response of the metallothionein promoter to ultraviolet radiation in human melanoma cells.

Hansen C, Ablett E, Green A, Sturm RA, Dunn IS, Fairlie DP, West ML, Parsons PG.

Photochem Photobiol. 1997 Mar;65(3):550-5.

PMID:
9077140
18.
19.
20.

Phage display of proteins.

Dunn IS.

Curr Opin Biotechnol. 1996 Oct;7(5):547-53. Review.

PMID:
8939620
21.

Inhibition of retinoblastoma protein translation by UVB in human melanocytic cells and reduced cell cycle arrest following repeated irradiation.

Pedley J, Ablett EM, Pettit A, Meyer J, Dunn IS, Sturm RA, Parsons PG.

Oncogene. 1996 Sep 19;13(6):1335-42.

PMID:
8808708
22.
23.

Purine deoxynucleoside metabolism in human melanoma cells with a high spontaneous mutation rate.

Musk P, Clark JM, Thompson D, Dunn IS, Christopherson RI, Szabados E, Rose SE, Parsons PG.

Mutat Res. 1996 Feb 19;350(1):229-38.

PMID:
8657185
24.
25.

Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family.

Sturm RA, O'Sullivan BJ, Box NF, Smith AG, Smit SE, Puttick ER, Parsons PG, Dunn IS.

Genomics. 1995 Sep 1;29(1):24-34.

PMID:
8530077
27.

Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.

Wong SS, Sturm RA, Michel J, Zhang XM, Danoy PA, McGregor K, Jacobs JJ, Kaushal A, Dong Y, Dunn IS, et al.

Biochem Pharmacol. 1994 Mar 2;47(5):827-37.

PMID:
7510966
29.
30.

Mutant forms of beta-galactosidase with an altered requirement for magnesium ions.

Dunn IS, Jennings PA.

Protein Eng. 1992 Jul;5(5):441-6.

PMID:
1518793
32.

Protein modification from mutational analysis of an autologous peptide fragment.

Dunn IS, Jennings PA.

Protein Eng. 1990 Dec;4(2):205-13.

PMID:
2127459
33.

Improved peptide function from random mutagenesis over short 'windows'.

Dunn IS, Cowan R, Jennings PA.

Protein Eng. 1988 Oct;2(4):283-91.

PMID:
3150542
34.

Regulation of murine contact sensitivity to urushiol components by serum factors.

Dunn IS, Liberato DJ, Stampf JL, Castagnoli N Jr, Byers VS.

J Invest Dermatol. 1987 Sep;89(3):296-8.

36.

Influence of chemical reactivity of urushiol-type haptens on sensitization and the induction of tolerance.

Dunn IS, Liberato DJ, Castagnoli N Jr, Byers VS.

Cell Immunol. 1986 Jan;97(1):189-96.

PMID:
3742608
37.
38.

Contact sensitivity to urushiol: role of covalent bond formation.

Dunn IS, Liberato DJ, Castagnoli N, Byers VS.

Cell Immunol. 1982 Dec;74(2):220-33. No abstract available.

PMID:
7165875
39.

A murine model system for contact sensitization to poison oak or ivy urushiol components.

Dunn IS, Liberato DJ, Dennick RG, Castagnoli N, Byers VS.

Cell Immunol. 1982 Apr;68(2):377-88. No abstract available.

PMID:
6178516
40.
41.

Subpopulations of splenic T and B lymphocytes producing and regulating leukocyte adherence inhibition factor.

Dunn IS, Halliday WJ.

Cell Immunol. 1980 Dec;56(2):465-77. No abstract available.

PMID:
7008959
42.

Interactions between T and B lymphocytes and macrophages in the production of leukocyte adherence inhibition factor.

Dunn IS, Halliday WJ.

Cell Immunol. 1980 Jun;52(1):48-61. No abstract available.

PMID:
6156012

Supplemental Content

Support Center